Akari Therapeutics Plc - ADR
NASDAQ:AKTX 11:43:12 AM EDT
Akari Therapeutics Plc - ADR Stock, NASDAQ:AKTX
22 Boston Wharf Road, 7th Floor, Boston, Massachusetts 02210
United States of America
Phone: +1.929.274.7510
Number of Employees: 12
Description
Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor. The company was founded on October 7, 2004 and is headquartered in Boston, MA.